Endobronchial autologous bone marrow–mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial

RATIONALE: Idiopathic pulmonary fibrosis (IPF) has a dismal prognosis. Mesenchymal stromal cells (MSCs) have shown benefit in other inflammatory diseases. OBJECTIVES: To evaluate the safety and feasibility of endobronchial administration of bone marrow autologous MSCs (BM-MSC) in patients with mild-...

Descripción completa

Detalles Bibliográficos
Autores principales: Campo, Arantza, González-Ruiz, José María, Andreu, Enrique, Alcaide, Ana B., Ocón, María M., De-Torres, Juan, Pueyo, Jesús, Cordovilla, Rosa, Villaron, Eva, Sanchez-Guijo, Fermín, Barrueco, Miguel, Nuñez-Córdoba, Jorge, Prósper, Felipe, Zulueta, Javier J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236617/
https://www.ncbi.nlm.nih.gov/pubmed/34195252
http://dx.doi.org/10.1183/23120541.00773-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236617/
https://www.ncbi.nlm.nih.gov/pubmed/34195252
http://dx.doi.org/10.1183/23120541.00773-2020

Ejemplares similares